4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one (Tetralone)

Holiness Pharmaceutical is a trusted and leading pharmaceutical intermediate exporter, supplier and manufacturer of 4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one (Tetralone), a key tetralone advanced intermediate used in the synthesis of Sertraline HCl API, a widely prescribed SSRI antidepressant. We supply high-purity intermediates to pharmaceutical manufacturers across 40+ international markets, supporting regulated and semi-regulated API production.

Globally, Holiness Pharmaceutical is recognized among reliable Sertraline intermediate manufacturers, offering consistent chemical purity, controlled chlorinated aromatic profiles, and stable physicochemical properties essential for downstream stereoselective steps. Our expertise in tetralone chemistry and CNS drug intermediates positions us as a dependable pharmaceutical intermediate exporter from India.

Our advanced intermediate manufacturing facilities operate in strict compliance with international quality standards including:
➡ DCGI, WHO-GMP aligned, and cGMP guidelines,
ensuring validated synthetic routes, batch-to-batch consistency, traceability, and comprehensive quality documentation.

We export this intermediate from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting API manufacturers focused on CNS and antidepressant therapies.

Holiness Pharmaceutical Ltd. is a fully integrated organization engaged in the complete lifecycle of intermediates — including route scouting, aromatic ketone synthesis, process optimization, commercial-scale manufacturing, and global supply of advanced intermediates for regulated APIs.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.